Cryoport President and CEO Jerrell W. Shelton Discusses the ‘Robust Demand’ of the Cell Therapy Market with BioPharma-Reporter

April 22, 2019

Cryoport has experienced remarkable growth in the past year: the company opened facilities in Amsterdam and Livingston, N.J., expanded its animal health services, hired several new employees, and announced an impressive 64% growth in FY 2018. 

This growth reflects a strong business strategy in a burgeoning industry. In a new interview with BioPharma-Reporter, Cryoport President and CEO Jerrell W. Shelton shares details about the company’s new deal with Celularity, the tremendous growth of the cell and gene therapy market, and how Cryoport’s specialized monitoring and temperature-controlled logistics support hundreds of packages being transported globally every day.  

Read the BioPharma-Reporter 

Related News 




Questions or comments? We welcome your feedback!

Email Us

Tags: Temperature Controlled Logistics, cold chain shipping, transportation, Cryoport News, Biopharma Industry News

Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC